Cargando…
Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer
BACKGROUND: Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261438/ https://www.ncbi.nlm.nih.gov/pubmed/34295758 http://dx.doi.org/10.21037/tau-20-1254 |